Equity Analyst, LightStream Research

Shifara Samsudeen, ACMA, CGMA

Equity Analyst

Long-Short Analysis on Japan, Asia and the World

LightStream Research

LightStream conducts quantitatively rigorous and data-driven analysis with a focus on Japan and Asia.

We consistently cover the Tech, Consumer and Industrial sectors, and provide ECM and Events coverage more broadly.

We supplement traditional qualitative insights from company relationships with a robust quantitative foundation that examines as much historical data as is available.
We further refine the accuracy of our insights and calls through the use of alternative data to flesh out current trends, and through a valuation framework that emphasises non-superficial peer group selection and a proper attempt to understand the metrics and changes that have driven security valuations in the past.

Equity Capital Markets

<a href="https://www.smartkarma.com/entities/cheerwin" target="_blank" data-smartkarma-citation="entities:31314:1" rel="noopener">Cheerwin (6601 HK)</a>  is a leading one-stop multi category household care and personal care platform in China. The company has set the terms for its IPO where it plans to raise HK$2.0-2.4bn (approx. US$265-313m) at an indicative IPO price range of HK$7.8-9.2 per share.In our previous insight, we discussed Cheerwin’s business model, segments and financials. Refer the extract below from our previous insight:<div class="content-highlight">The household care market in China is forecasted to grow steadily over the next few years driven by increased urbanisation, growing per capita disposable income, segmentation of product categories and growing innovation. In addition, the Covid-19 outbreak also has accelerated the demand for household care products, especially disinfectants, hand sanitizers and other personal hygiene products. Though the company’s revenues have been growing at lower single digits, we believe strong growth prospects attached to the Chinese household care market alongside diversifying into other verticals such as pet care and personal care markets should help Cheerwin generate stable revenues</div>

Cheerwin (6601 HK)  is a leading one-stop multi category household care and personal care platform in China. The company has set the terms for its IPO where it plans to raise HK$2.0-2.4bn (approx. US$265-313m) at an indicative IPO price range of HK$7.8-9.2 per share.In our previous insight, we discussed Cheerwin’s business model, segments and financials. Refer the extract below from our previous insight:The household care market in China is forecasted to grow steadily over the next few years driven by increased urbanisation, growing per capita disposable income, segmentation of product categories and growing innovation. In addition, the Covid-19 outbreak also has accelerated the demand for household care products, especially disinfectants, hand sanitizers and other personal hygiene products. Though the company’s revenues have been growing at lower single digits, we believe strong growth prospects attached to the Chinese household care market alongside diversifying into other verticals such as pet care and personal care markets should help Cheerwin generate stable revenues

Cheerwin IPO: Fairly Valued Compared to Recent IPOs in the Household, Personal and Pet Care Markets

Investment Research - Asia Consumer Sector, Investory

Devi Subhakesan

Investment Research - Asia Consumer Sector

ASIA CONSUMER: INSIGHTS AND INVESTMENT IDEAS

Investory

Investory is a Singapore-based boutique independent equity research firm founded in January 2017 with a primary focus on consumption themes across Asia-Pacific.

We aim to generate investible ideas based on consumption trends and outlook. We screen our ideas on several parameters - product potential, long-term growth and management commitment being the most critical.  We follow a fundamental analysis approach in our stock selection process and are not restricted by market cap.

We aspire to grow into a leading source of unbiased research, free of conflict of interest, for investors yearning for independent and disciplined analysis. 

We also undertake bespoke research mandates to support our Institutional clients’ investment needs.

Our team comprises of professionals with extensive experience in the Asian equity markets, in areas ranging from research, servicing institutional clients and investment management.

Thematic (Sector/Industry)

In this Smartkarma Original Series report, we look at how the pet care industry in Asia, specifically China, grew 10x fold in the past 10 years and what sets it apart. Compared to the west, the pet care industry is a relatively recent development in emerging Asia. It is still early days of growth and evolution for the various segments of the industry and local players are still trying to establish a meaningful presence in most categories. However, the unique social/demographic factors that have spurred the pet boom in China has also opened up new product needs that are being addressed by local players - smart petting gadgets being one of them. Investors have been active in segments where local players have established a strong presence, like medical facilities; an IPO is reportedly on the anvil in 2021. This could attract more market attention to this high-growth sector especially if investors get an option to ride the sector growth. 
What is original about this report? In this report, we analyse the data available on Pet ownership in Asia, predominantly China, and compare it with the US to understand and assess the scope of growth for Asia's pet care sector. We study the underlying factors driving the pet boom and spending spree in China and discuss the various segments of the pet care industry and highlight emerging trends and pockets of opportunity. Lastly, we scan the Asia-based branded pet industry space in each segment, to select and study players that have built a meaningful presence in the market place. We see attractive growth potential for many of the early entrants - listed and unlisted- in the sector. We believe there is room for more branded players to enter the industry and tap into the existing and emerging product white spaces.

In this Smartkarma Original Series report, we look at how the pet care industry in Asia, specifically China, grew 10x fold in the past 10 years and what sets it apart. Compared to the west, the pet care industry is a relatively recent development in emerging Asia. It is still early days of growth and evolution for the various segments of the industry and local players are still trying to establish a meaningful presence in most categories. However, the unique social/demographic factors that have spurred the pet boom in China has also opened up new product needs that are being addressed by local players - smart petting gadgets being one of them. Investors have been active in segments where local players have established a strong presence, like medical facilities; an IPO is reportedly on the anvil in 2021. This could attract more market attention to this high-growth sector especially if investors get an option to ride the sector growth. 
What is original about this report? In this report, we analyse the data available on Pet ownership in Asia, predominantly China, and compare it with the US to understand and assess the scope of growth for Asia's pet care sector. We study the underlying factors driving the pet boom and spending spree in China and discuss the various segments of the pet care industry and highlight emerging trends and pockets of opportunity. Lastly, we scan the Asia-based branded pet industry space in each segment, to select and study players that have built a meaningful presence in the market place. We see attractive growth potential for many of the early entrants - listed and unlisted- in the sector. We believe there is room for more branded players to enter the industry and tap into the existing and emerging product white spaces.

Pet Care Sector in Asia: Saga Has Just Started. Opportunities Galore.

Boqii is one of the largest pet-focused platforms in China who offers a one-stop destination for pet parents to get everything they need for their pets including pet food, toys, vitamins and toiletries. The company operates an online platform as well as an offline retail network.The company has filed for an IPO to list its shares in the US at an indicative price range of US$10-12 per ADS and will raise a maximum of US$96m if underwriters exercise their options.In our previous insight on the company’s IPO <a href="https://www.smartkarma.com/insights/boqii-ipo-another-pet-humanization-stock-in-a-booming-market-led-by-large-e-commerce-platforms" target="_blank" data-smartkarma-citation="insights:43133" rel="noopener">Boqii IPO: Another Pet Humanization Stock in a Booming Market Led by Large E-Commerce Platforms</a> , we examined the company’s business model, sources of revenue and the industry in which the company operates. In this insight, we examine the attractiveness of the company’s financials.

Boqii is one of the largest pet-focused platforms in China who offers a one-stop destination for pet parents to get everything they need for their pets including pet food, toys, vitamins and toiletries. The company operates an online platform as well as an offline retail network.The company has filed for an IPO to list its shares in the US at an indicative price range of US$10-12 per ADS and will raise a maximum of US$96m if underwriters exercise their options.In our previous insight on the company’s IPO Boqii IPO: Another Pet Humanization Stock in a Booming Market Led by Large E-Commerce Platforms , we examined the company’s business model, sources of revenue and the industry in which the company operates. In this insight, we examine the attractiveness of the company’s financials.

Boqii IPO: Intense Price Competition Impacts Top Line Growth and Eat into Margins

GoodRx Holdings Inc / Equity Capital Markets

GoodRx (GDRX) offers a prescription aggregation platform in the US enabling healthcare professionals to provide prices from the platform directly to their patients at the point of prescribing. In addition, the company also offers telehealth services since 2019 through its own platform HeyDoctor and GoodRx telehealth marketplace.The company has filed for an IPO in the US and intends to raise around US$900m. In addition, GoodRx will also raise US$100m from a private placement from Silver Lake concurrent to its IPO.A majority of the recent IPOs in the US commanded lofty valuations despite them making massive losses while some of them did not even have a proper path to profitability. However, GoodRx has strong financials with a growing top line and track record of profits, and the company dominates a growing market.We discuss the details below.

GoodRx (GDRX) offers a prescription aggregation platform in the US enabling healthcare professionals to provide prices from the platform directly to their patients at the point of prescribing. In addition, the company also offers telehealth services since 2019 through its own platform HeyDoctor and GoodRx telehealth marketplace.The company has filed for an IPO in the US and intends to raise around US$900m. In addition, GoodRx will also raise US$100m from a private placement from Silver Lake concurrent to its IPO.A majority of the recent IPOs in the US commanded lofty valuations despite them making massive losses while some of them did not even have a proper path to profitability. However, GoodRx has strong financials with a growing top line and track record of profits, and the company dominates a growing market.We discuss the details below.

GoodRx IPO: A Healthy Prescription for Strong Topline Growth and Profits

ZTO Express Cayman  / Equity Capital Markets

The leading Chinese express delivery company, ZTO Express is looking to raise US$1.56bn (45m shares at a maximum offer price of US$34.58 per share) in its Hong Kong Secondary listing, following in the footsteps of a growing number of US-listed Chinese companies seeking for secondary listings.The company utilises a “network partner model” (referred as “Tongda operators”) where the mission-critical line-haul transportation and sorting within the express value chain is handled by the company itself, while the network partners operate the outlets that provide first-mile pickup and last-mile delivery services.We discuss the details below.

The leading Chinese express delivery company, ZTO Express is looking to raise US$1.56bn (45m shares at a maximum offer price of US$34.58 per share) in its Hong Kong Secondary listing, following in the footsteps of a growing number of US-listed Chinese companies seeking for secondary listings.The company utilises a “network partner model” (referred as “Tongda operators”) where the mission-critical line-haul transportation and sorting within the express value chain is handled by the company itself, while the network partners operate the outlets that provide first-mile pickup and last-mile delivery services.We discuss the details below.

ZTO Secondary: Entire Industry Expanding Capacity While Facing Pricing Pressure Is Not a Good Thing

China

Boqii Holding Limited opeates as a holding company. The Company, through its subsidiaries, retails pet related products such as pet foods and accessories. Boqii Holding serves customers in China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Boqii Holding (BQ US)

Cheerwin IPO: Fairly Valued Compared to Recent IPOs in the Household, Personal and Pet Care Markets

Cheerwin is a leading one-stop multi category household care and personal care platform in China. The company has set the terms for its IPO where...

Shifara Samsudeen, ACMA, CGMA

Pet Care Sector in Asia: Saga Has Just Started. Opportunities Galore.

Asia pet care industry is in the early stages of growth. Attractive product white spaces for new entrants. Notable Asia based players profiled....

Devi Subhakesan

Boqii IPO: Intense Price Competition Impacts Top Line Growth and Eat into Margins

Boqii is one of the largest pet-focused platforms in China who offers a one-stop destination for pet parents to get everything they need for their...

Shifara Samsudeen, ACMA, CGMA

GoodRx IPO: A Healthy Prescription for Strong Topline Growth and Profits

GoodRx (GDRX) offers a prescription aggregation platform in the US enabling healthcare professionals to provide prices from the platform directly...

Shifara Samsudeen, ACMA, CGMA

ZTO Secondary: Entire Industry Expanding Capacity While Facing Pricing Pressure Is Not a Good Thing

The leading Chinese express delivery company, ZTO Express is looking to raise US$1.56bn (45m shares at a maximum offer price of US$34.58 per share)...

Shifara Samsudeen, ACMA, CGMA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)